Ipatasertib Recruiting Phase 2 Trials for Cancer, Breast / Estrogen Receptor-Positive Breast Cancer Other

IndicationsStatusPurposePhase
RecruitingOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT03395899Pre-operative Immunotherapy Combination Strategies in Breast Cancer